Cardiac energy metabolism in obesity

被引:240
作者
Lopaschuk, Gary D. [1 ]
Folmes, Clifford D. L.
Stanley, William C.
机构
[1] Univ Alberta, Heritage Med Res Ctr 423, Edmonton, AB T6G 2S2, Canada
[2] Univ Alberta, Cardiovasc Res Grp, Edmonton, AB T6G 2S2, Canada
[3] Univ Maryland, Dept Med, Div Cardiol, Baltimore, MD 21201 USA
关键词
fatty acid oxidation; adiponectin; leptin; malonyl-coenzyme A; PPAR alpha; glycolysis;
D O I
10.1161/CIRCRESAHA.107.150417
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity results in marked alterations in cardiac energy metabolism, with a prominent effect being an increase in fatty acid uptake and oxidation by the heart. Obesity also results in dramatic changes in the release of adipokines, such as leptin and adiponectin, both of which have emerged as important regulators of cardiac energy metabolism. The link among obesity, cardiovascular disease, lipid metabolism, and adipokine signaling is complex and not well understood. However, optimizing cardiac energy metabolism in obese subjects may be one approach to preventing and treating cardiac dysfunction that can develop in this population. This review discusses what is presently known about the effects of obesity and the impact adipokines have on cardiac energy metabolism and insulin signaling. The clinical implications of obesity and energy metabolism on cardiac disease are also discussed.
引用
收藏
页码:335 / 347
页数:13
相关论文
共 193 条
[1]   Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice [J].
Aasum, E ;
Hafstad, AD ;
Severson, DL ;
Larsen, TS .
DIABETES, 2003, 52 (02) :434-441
[2]   Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-α activator [J].
Aasum, E ;
Belke, DD ;
Severson, DL ;
Riemersma, RA ;
Cooper, M ;
Andreassen, M ;
Larsen, TS .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (03) :H949-H957
[3]  
Abel E. Dale, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P219, DOI 10.2174/1568008054064869
[4]   Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2 [J].
Abu-Elheiga, L ;
Matzuk, MM ;
Abo-Hashema, KAH ;
Wakil, SJ .
SCIENCE, 2001, 291 (5513) :2613-2616
[5]  
Agata J, 1997, AM J HYPERTENS, V10, P1171
[6]   Adipose tissue as an endocrine organ [J].
Ahima, Rexford S. .
OBESITY, 2006, 14 :242-249
[7]   Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance [J].
An, J ;
Muoio, DM ;
Shiota, M ;
Fujimoto, Y ;
Cline, GW ;
Shulman, GI ;
Koves, TR ;
Stevens, R ;
Millington, D ;
Newgard, CB .
NATURE MEDICINE, 2004, 10 (03) :268-274
[8]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[9]   Atkins and other low-carbohydrate diets: hoax or an effective tool for weight loss? [J].
Astrup, A ;
Larsen, TM ;
Harper, A .
LANCET, 2004, 364 (9437) :897-899
[10]   Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats [J].
Atkinson, LL ;
Kozak, R ;
Kelly, SE ;
Onay-Besikci, A ;
Russell, JC ;
Lopaschuk, GD .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (05) :E923-E930